Comprehensive Assessment of Cancer Theranostic Response

NARecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 2, 2024

Primary Completion Date

March 30, 2026

Study Completion Date

May 29, 2026

Conditions
Prostate Cancer
Interventions
DEVICE

TRAQinform Theranostics

This prospective, multi-center, non-interventional clinical study will evaluate actionable outputs from TRAQinform Theranostics, a software only medical device that identifies, quantifies, tracks, and compares lesions between different imaging modalities and multiple imaging timepoints.

Trial Locations (2)

10065

RECRUITING

Weill Medical College of Cornell, New York

77030

RECRUITING

M.D. Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Weill Medical College of Cornell University

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

lead

AIQ Solutions

INDUSTRY

NCT06815354 - Comprehensive Assessment of Cancer Theranostic Response | Biotech Hunter | Biotech Hunter